SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-018598
Filing Date
2016-05-09
Accepted
2016-05-09 16:25:14
Documents
50
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q fgen-10q_20160331.htm 10-Q 2083226
2 EX-10.4 fgen-ex104_138.htm EX-10.4 22088
3 EX-31.1 fgen-ex311_9.htm EX-31.1 8183
4 EX-31.2 fgen-ex312_15.htm EX-31.2 8179
5 EX-32.1 fgen-ex321_16.htm EX-32.1 6991
  Complete submission text file 0001564590-16-018598.txt   6109282

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT fgen-20160331.xml EX-101.INS 1353764
7 XBRL TAXONOMY EXTENSION SCHEMA fgen-20160331.xsd EX-101.SCH 33600
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fgen-20160331_cal.xml EX-101.CAL 47702
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fgen-20160331_def.xml EX-101.DEF 103864
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE fgen-20160331_lab.xml EX-101.LAB 255871
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fgen-20160331_pre.xml EX-101.PRE 207919
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36740 | Film No.: 161632007
SIC: 2834 Pharmaceutical Preparations